SciClone Pharmaceuticals, Inc. (SciClone ) is a global specialty pharmaceutical company. It has a product portfolio of therapies for cancer and infectious diseases. SciClone has in-licensed two products that are part of this international commercial growth strategy, DC Bead and ondansetron RapidFilm. Its DC Bead product candidate is a treatment for liver cancer, which is approved in 40 countries worldwide, including Europe and the United States. Ondansetron RapidFilm is an oral thin film formulation of ondansetron used to treat and prevent nausea and vomiting caused by chemotherapy, radiotherapy and surgery. SCV-07 is being developed for the delay of onset of severe oral mucositis in patients receiving chemoradiation therapy for the treatment of cancers of the head and neck and for the treatment of hepatitis C virus (HCV). Thymalfasin is being developed in an ongoing clinical trial for improvement of Influenza A (H1N1) vaccination.

sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Develops pharmaceutical products

Viral Technologies, Inc., part of CEL-SCI Corp., is a company headquartered in Vienna, VA, that manufactures pharmaceutical and vaccine products.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Xiamen Bosay Gene Transcription Technology Co., Ltd., established on 2002-01-28, Business scope includes general items:Natural science research and experimental development;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;R&D and application of cell technology;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology intermediary service;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Cosmetics Wholesale;Cosmetics Retail;Personal Hygiene Sales;Non-residential real estate leases.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

The National Centre of Scientific Research "Demokritos" (NRCPS; Greek: Εθνικό Κέντρο Έρευνας Φυσικών Επιστημών (Ε.Κ.Ε.Φ.Ε.) "Δημόκριτος") is a research center in Greece, employing over 1,000 researchers, engineers, technicians and administrative personnel. It focuses on several fields of natural sciences and engineering and hosts laboratory facilities.

Replicor is a clinical-stage company developing novel NUCLEIC ACID-BASED POLYMERS (NAPs): oligonucleotides whose antiviral activity is strictly dependent on the polymer chemistry of oligonucleotides which can be preserved independently of the sequence of nucleotides present. NAPs have a very important safety advantage over all other existing oligonucleotide-based drugs such as aptamers, antisense oligonucleotides and siRNA: because NAP’s activity is not sequence dependent, NAPs can be engineered with sequences which retain antiviral activity but which do not have pro-inflammatory activity or off target effects common with other oligonucleotide-based drugs, rendering them safe and well tolerated.

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Suzhou Tianma Pharmaceutical Group Tianji Bio-Pharmaceutical Co., Ltd., established on 2000-06-21, The scope of business includes the production of raw materials(thymosin alpha1,Octreotide Acetate,Carbetocin,triptorelin acetate,desmopressin acetate,terlipressin acetate),small volume injection,powder injection,Freeze-dried powder injection,Sales of company-produced products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Domestic trade agent;Economic and Trade Consulting;sales agent(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Sclavo Spa is an Italian private company located in Siena that operates as a laboratory.

Part of Lonza Group AG, Lonza Ltd. is a company headquartered in Basel, Switzerland, that supplies chemicals for pharmacy industry.

Engages in developing, producing and selling pharmaceutical and chemical products

Part of Changchun High & New Technology Industries (Group), Inc., Changchun Genescience Pharmaceuticals Co., Ltd. is a Chinese company located in Changchun. The firm manufactures pharmaceuticals products. It was founded in 1997. Lei Jin is the current CEO of the firm.